Abyrx Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

Abyrx General Information

Description

Developer of therapeutic devices designed to offer efficiency in surgical procedures. The company's devices include resorbable hemostatic bone putty which is used during ortho, cranial, maxillofacial, trauma, cardiothoracic, and spine procedures and adheres to bleeding bone surfaces, enabling patients to ensure fast recovery with the use of advanced treatment.

Contact Information

Website
www.abyrx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 700 Fairfield Avenue
  • Suite 1
  • Stamford, CT 06902
  • United States
+1 (855)
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Parent Company
MedEdge Holdings
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 700 Fairfield Avenue
  • Suite 1
  • Stamford, CT 06902
  • United States
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abyrx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 24-Nov-2025 Completed Product Development
2. Early Stage VC 06-Dec-2016 Completed Product Development
1. Merger of Equals 24-Apr-2013 Completed Startup
To view Abyrx’s complete valuation and funding history, request access »

Abyrx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic devices designed to offer efficiency in surgical procedures. The company's devices include reso
Therapeutic Devices
Stamford, CT
16 As of 2025

Paris, France
 

Glostrup, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abyrx Competitors (23)

One of Abyrx’s 23 competitors is TISSIUM, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TISSIUM Venture Capital-Backed Paris, France
LiNA Medical Corporation Glostrup, Denmark
Artivion Formerly PE-Backed Kennesaw, GA
Elixir Medical Venture Capital-Backed Milpitas, CA
Medtronic Corporation Minneapolis, MN
You’re viewing 5 of 23 competitors. Get the full list »

Abyrx Patents

  • 124

    Total Documents Applications and Grants

  • Total Patents Families

  • 82

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Abyrx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12564655-B1 Settable surgical compositions and methods of use Active 12-Dec-2023
US-20260183445-A1 Settable surgical compositions and methods of use Pending 12-Dec-2023
EP-4590241-A1 Molds for settable multi-component compositions and method of forming said compositions Pending 22-Sep-2022
US-20260130766-A1 Molds for settable multi-component compositions and method of forming said compositions Pending 22-Sep-2022
WO-2024064891-A1 Molds for settable multi-component compositions and method of forming said compositions Inactive 22-Sep-2022 A61F2/30942
To view Abyrx’s complete patent history, request access »

Abyrx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abyrx Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BB Biotech Asset Manager Minority
Canaan Partners Venture Capital Minority
Med Edge Corporation Minority
The Edge Group Venture Capital Minority
To view Abyrx’s complete investors history, request access »

Abyrx Acquisitions (2)

Abyrx’s most recent deal was a Merger of Equals with Doctors Research Group. The deal was made on 24-Apr-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Doctors Research Group 24-Apr-2013 Merger of Equals Surgical Devices
ORTHOCON 24-Apr-2013 Merger of Equals Surgical Devices
To view Abyrx’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Abyrx FAQs

  • When was Abyrx founded?

    Abyrx was founded in 2013.

  • Where is Abyrx headquartered?

    Abyrx is headquartered in Stamford, CT.

  • What is the size of Abyrx?

    Abyrx has 16 total employees.

  • What industry is Abyrx in?

    Abyrx’s primary industry is Therapeutic Devices.

  • Is Abyrx a private or public company?

    Abyrx is a Private company.

  • What is Abyrx’s current revenue?

    The current revenue for Abyrx is .

  • How much funding has Abyrx raised over time?

    Abyrx has raised $10M.

  • Who are Abyrx’s investors?

    BB Biotech, Canaan Partners, Med Edge, and The Edge Group have invested in Abyrx.

  • Who are Abyrx’s competitors?

    TISSIUM, LiNA Medical, Artivion, Elixir Medical, and Medtronic are some of the 23 competitors of Abyrx.

  • When was Abyrx acquired?

    Abyrx was acquired on 24-Nov-2025.

  • Who acquired Abyrx?

    Abyrx was acquired by MedEdge Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process